Alzamend Neuroâ˘, Inc. (âAlzamendâ˘â) is a biotechnology company dedicated to the research, development and commercialization of pharmaceuticals for the treatment and cure of Alzheimerâs disease. Alzamend Neuro⢠is currently working to transition two therapeutics targeting Alzheimerâs disease (âADâ) from the research and preclinical stage at the University of South Florida into the clinical stage and towards full commercialization. Alzamend Neuro⢠has licensed both a patented mutant-peptide immunotherapeutic (CAO22W) for use as a treatment or vaccine and a lithium based ionic cocrystal therapy (LiProSalâ˘) that may greatly reduce or eliminate the symptoms of agitation and other endpoints for mild to moderate stage patients diagnosed with AD. There are no profound treatments today for Alzheimerâs disease. With CAO22W and LiProSalâ˘, the Company believes that Alzamend⢠can change that.
No articles found.
Bringing faster healthier wound healing outcomes to trauma, burn victims and diabe...
Bringing faster healthier wound healing outcome...
We are a vertically integrated, clinical stage gene therapy company with four ongo...
We are a vertically integrated, clinical stage ...
GluCase is an all-in-one diabetes management system that seamlessly integrates a g...
GluCase is an all-in-one diabetes management sy...
Coherus BioSciences is a leading biosimilar company that develops and commercializ...
Coherus BioSciences is a leading biosimilar com...
SINTX Technologies is an OEM ceramics company that develops and commercializes sil...
SINTX Technologies is an OEM ceramics company t...
Ionis is a sustainably profitable, multi-product company with a pipeline of more t...
Ionis is a sustainably profitable, multi-produc...
Count.It connects with wearable tracking devices and apps to power community fitne...
Count.It connects with wearable tracking device...
Flagship Fitness operates an upscale fitness and wellness facility in Ramsey, MN, ...
Flagship Fitness operates an upscale fitness an...
Our current primary focus verticals are the US human and pet wellness CBD market a...
Our current primary focus verticals are the US ...
Cortexyme is a biopharmaceutical company developing therapeutics based on data sup...
Cortexyme is a biopharmaceutical company develo...
Join the National Investor Network and get the latest information with your interests in mind.